Flowers Foods, Inc. (NYSE: FLO) has reported its financial results for the 16-week first quarter ended April 19, 2025. The company's net sales decreased by 1.4% to $1.554 billion compared to the prior year's first quarter. The net income decreased by 27.4% to $53.0 million, representing 3.4% of sales, a 120-basis point decrease. Adjusted net income decreased by 8.2% to $73.7 million, and adjusted EBITDA increased by 1.6% to $162.0 million, representing 10.4% of net sales, a 30-basis point increase.
The company completed the acquisition of Simple Mills, which contributed $24.3 million in net sales, a net loss of $4.2 million, $3.6 million to adjusted EBITDA, and ($0.02) diluted EPS.
The outlook for the 53-week fiscal 2025 includes net sales of approximately $5.297 billion to $5.395 billion, representing 3.8% to 5.7% growth compared to the prior year. Adjusted EBITDA is expected to be in the range of approximately $534 million to $562 million, and adjusted diluted EPS is expected to be approximately $1.05 to $1.15.
In the first quarter of 2025, cash flow from operating activities increased to $135.6 million, capital expenditures decreased to $25.6 million, and dividends paid to shareholders increased to $52.3 million. The company's cash and cash equivalents were $7.3 million at the end of the quarter.
Flowers Foods remains optimistic about the growth potential of its leading brands and is focusing on innovation and targeting opportunities in faster-growing categories and adjacencies to mitigate category weakness.
The company's chairman and CEO, Ryals McMullian, expressed confidence in the company's ability to drive shareholder value and deliver results consistent with its long-term financial targets.
Flowers Foods, Inc. is one of the largest producers of packaged bakery foods in the United States, with top brands including Nature’s Own, Dave’s Killer Bread, Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. As a result of these announcements, the company's shares have moved 0.26% on the market, and are now trading at a price of $17.115. For more information, read the company's full 8-K submission here.